Celgene

This study tested a drug called CC-93538 in 48 Japanese adults and teenagers with eosinophilic gastroenteritis, a condition where certain white blood cells build up in the gut and cause pain, bloating, and diarrhea. The goal was to see if the drug could reduce those cells and eas…

This study looked at the long-term safety of an oral chemotherapy drug (azacitidine) in 5 adults with blood cancers who had already taken it in earlier studies. Researchers tracked side effects and survival over time. The goal was to see if continuing the drug was safe and benefi…

This early-phase study tested an experimental drug called CC-94676 in 131 men with a type of advanced prostate cancer that has stopped responding to standard hormone treatments. The main goals were to check the drug's safety, find the right dose, and see if it could lower PSA lev…

This study tested a new treatment called bb2121 in about 312 people with multiple myeloma, a type of blood cancer. It included patients whose cancer had returned or was hard to treat, as well as those at high risk. The goal was to see if bb2121 could shrink tumors or lead to remi…

This study looked at the long-term safety and effectiveness of an oral medication called RPC1063 for people with moderate to severe ulcerative colitis. It included 877 participants who had already taken the drug in earlier studies. The main goal was to track side effects, and res…

This study looked at the long-term safety of an experimental drug called CC-93538 for people with eosinophilic esophagitis, a condition where the esophagus becomes inflamed and swollen. It included 367 adults and teenagers who had already taken part in earlier studies of the same…

This study tested a drug called luspatercept in 30 Chinese and Japanese adults with a bone marrow condition (MDS) that causes severe anemia. Participants needed regular red blood cell transfusions. The goal was to see if the drug could help them go at least 8 weeks without a tran…

This study tested two doses of an oral medication called ozanimod in 198 Japanese adults with moderate-to-severe ulcerative colitis. The goal was to see if the drug could reduce symptoms like diarrhea and rectal bleeding better than a placebo. Participants took the drug daily for…

This study looked at how the drug golcadomide is handled by the body in people with moderate or severe liver damage compared to healthy volunteers. 29 adults received a single dose to measure drug levels and check for side effects. The goal was to understand dosing needs for pati…